GR1001459B - Σύμπλεγμα συζυγών φαρμάκων με αντισώματα. - Google Patents

Σύμπλεγμα συζυγών φαρμάκων με αντισώματα.

Info

Publication number
GR1001459B
GR1001459B GR920100429A GR920100429A GR1001459B GR 1001459 B GR1001459 B GR 1001459B GR 920100429 A GR920100429 A GR 920100429A GR 920100429 A GR920100429 A GR 920100429A GR 1001459 B GR1001459 B GR 1001459B
Authority
GR
Greece
Prior art keywords
insoindoline
derivatives
production
optically active
conjugates
Prior art date
Application number
GR920100429A
Other languages
English (en)
Inventor
Gary Allen Koppel
E Robin Offord
Keith Rose
William Leonard Scott
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR1001459B publication Critical patent/GR1001459B/el

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

Δίδονται συζυγιακές ενώσεις φαρμάκων κατευθυνόμενες προς ένα στόχο, οι οποίες καθιστούν δυνατόν να κατευθυνθεί εις ένα κύτταρον ένας μεγάλος αριθμός μορίων φαρμάκου δι' ενός μόνον μορίου αντισώματος. Η εφεύρεσις δίδει επίσης ενδιάμεσες ενώσεις δια την σύνθεσιν τέτοιων συζυγιακών ενώσεων και κυτταροτοξικών φαρμάκων, οι οποίες έχουν τροποποιηθεί συμφώνως προς την αρχήν ομάδος της εφευρέσεως.ω
GR920100429A 1992-10-08 1992-10-08 Σύμπλεγμα συζυγών φαρμάκων με αντισώματα. GR1001459B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR92100429 1992-10-08

Publications (1)

Publication Number Publication Date
GR1001459B true GR1001459B (el) 1993-12-30

Family

ID=10941198

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100429A GR1001459B (el) 1992-10-08 1992-10-08 Σύμπλεγμα συζυγών φαρμάκων με αντισώματα.

Country Status (1)

Country Link
GR (1) GR1001459B (el)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088695A2 (en) * 1982-03-09 1983-09-14 Cytogen Corporation Antibody conjugates
EP0328147A2 (en) * 1988-02-11 1989-08-16 Bristol-Myers Squibb Company Anthracycline immunoconjugates having a novel linker and methods for their production
EP0354729A2 (en) * 1988-08-08 1990-02-14 Eli Lilly And Company Cytotoxic drug conjugates
EP0354728A2 (en) * 1988-08-08 1990-02-14 Eli Lilly And Company Cytotoxic drug conjugates
WO1991013097A1 (en) * 1990-02-28 1991-09-05 Robin Ewart Offord Polyaminocarboxylic acid derivatives
EP0175617B1 (en) * 1984-09-13 1991-10-30 Cytogen Corporation Antibody-therapeutic agent conjugates
EP0476408A1 (en) * 1990-09-17 1992-03-25 Research Corporation Technologies, Inc. Chemical conjugation of morpholino anthracyclines to antibodies

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088695A2 (en) * 1982-03-09 1983-09-14 Cytogen Corporation Antibody conjugates
EP0175617B1 (en) * 1984-09-13 1991-10-30 Cytogen Corporation Antibody-therapeutic agent conjugates
EP0328147A2 (en) * 1988-02-11 1989-08-16 Bristol-Myers Squibb Company Anthracycline immunoconjugates having a novel linker and methods for their production
EP0354729A2 (en) * 1988-08-08 1990-02-14 Eli Lilly And Company Cytotoxic drug conjugates
EP0354728A2 (en) * 1988-08-08 1990-02-14 Eli Lilly And Company Cytotoxic drug conjugates
WO1991013097A1 (en) * 1990-02-28 1991-09-05 Robin Ewart Offord Polyaminocarboxylic acid derivatives
EP0476408A1 (en) * 1990-09-17 1992-03-25 Research Corporation Technologies, Inc. Chemical conjugation of morpholino anthracyclines to antibodies

Similar Documents

Publication Publication Date Title
ATE234635T1 (de) Verzweigte hydrazongruppen enthaltende kuppler
RU95108590A (ru) Производные имидазола
MX9403570A (es) Conjugados de farmaco-ligando, proceso para su preparacion y composicionesfarmaceuticas que los incluyen.
CY1113856T1 (el) Διεργασια για την παραγωγη φαρμακοτεχνικων μορφων τριοξειδιου του αρσενικου
CY1113258T1 (el) Συμπλοκο φυλλικου- βινβλαστινης ως φαρμακο
HUP0100949A2 (hu) Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények
FR2741066B1 (fr) Nouveaux agents de transfection et leurs applications pharmaceutiques
AR005458A1 (es) 2-oxo-y 2-tio-1,2-dihidroquinolinil-oxazolidinonas, procedimiento para su produccion, el uso de las mismas para la produccion de un medicamento ymedicamentos que los contienen
DK434188D0 (da) Antistof-enzymkonjugater i kombination med prolaegemidler til fremfoering af cytotoxiske midler til tumorceller
BR9508308A (pt) Derivados de benzoíla e sintese dos mesmos
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
TR199902382T2 (xx) Yeni 2-(�minometil) amino-fenil t�revleri, bunlar� i�eren farmas�tik terkiplerin ila� olarak haz�rlanmas� ve uygulanmas�.
Kupczyk-Subotkowska et al. Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand− melphalan conjugate
BRPI0411800A (pt) candidatos a fármacos e métodos para sua preparação
GR1001459B (el) Σύμπλεγμα συζυγών φαρμάκων με αντισώματα.
FR2422405A1 (fr) Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique
DE69132044D1 (de) Markierte, modifizierte Oligonokleotiden
WO1996015240A3 (en) Ribozyme analogs
PT1064262E (pt) Isoindolonas substituidas e a sua utilizacao como moduladores de gmp ciclico em farmacos
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
FR2421616A1 (fr) Nouveaux medicaments constitues de derives de l'acide o-aminobenzoique
RU94036769A (ru) Алкильные производные тразодона, способ их получения, промежуточные соединения и фармацевтическая композиция
BR0008681A (pt) Derivados de 3-amino -3-arilpropan-1-ol, processo para sua obtenção, medicamento e seu uso
PT889885E (pt) Processo de proteccao selectiva de derivados da bacatina e sua utilizacao na sintese de taxanos